Apellis Pharmaceuticals Price Chart
*There is no price data available for this ticker
Apellis Pharmaceuticals Volume Chart
*There is no volume data available for this ticker
Apellis Pharmaceuticals Market Segments
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
+0.02(+0.05%)
| Open | $41.04 |
|---|---|
| Close | $41.06 |
| Low | $41.03 |
| Low Change | -0.01 (-0.02%) |
| High | $41.06 |
| High Change | +0.02 (+0.05%) |
| Range | $0.03 |
| Volume | 8.326M |
| Dollar Volume | $341.87M |
Regular Trading Hours Yesterday
-0.01(-0.02%)
| Open | $41.05 |
|---|---|
| Close | $41.04 |
| Low | $41.03 |
| Low Change | -0.02 (-0.05%) |
| High | $41.07 |
| High Change | +0.02 (+0.05%) |
| Range | $0.04 |
| Volume | 28.528M |
| Dollar Volume | $1.17B |
Premarket Yesterday
+0.01(+0.02%)
| Open | $41.04 |
|---|---|
| Close | $41.05 |
| Low | $41.04 |
| Low Change | 0.00 (0.00%) |
| High | $41.08 |
| High Change | +0.04 (+0.10%) |
| Range | $0.04 |
| Volume | 84.236K |
| Dollar Volume | $3.46M |
Apellis Pharmaceuticals Moving Averages
| 5 Day Moving Average (SMA5) | $41.04 |
|---|---|
| 10 Day Moving Average (SMA10) | $41.01 |
| 20 Day Moving Average (SMA20) | $40.97 |
| 50 Day Moving Average (SMA50) | $32.36 |
| 100 Day Moving Average (SMA100) | $27.66 |
| 200 Day Moving Average (SMA200) | $25.81 |
Apellis Pharmaceuticals Statistics
| Average Volume (30 Days) | 8.51M |
|---|---|
| P/E Ratio (Current) | 228.11 |
| EPS (Current) | $0.18 |
| Dividend Yield | 0.00% |
| Free Cash Flow | $45.01M |
| Cash Ratio | 1.44 |
| Current Ratio | 3.13 |
| Quick Ratio | 2.69 |
| Debt to Equity | 1.23 |
| Enterprise Value | $5.25B |
| EV to EBITDA | 92.05 |
| EV to Sales | 5.23 |
| Price to Book | 14.20 |
| Price to Cash Flow | 115.97 |
| Price to Free Cash Flow | 116.78 |
| Price to Sales | 5.24 |
| Return on Assets | 0.02% |
| Return on Equity | 0.06% |
Apellis Pharmaceuticals Stock Splits
There has been 1 stock split for Apellis Pharmaceuticals (APLS). The reverse stock split occured on March 19, 2004 and reduced the outstanding shares at a ratio of 200:1.
| Date | Type | Ratio |
|---|---|---|
| Mar 19, 2004 | Reverse | 200:1 |
Apellis Pharmaceuticals Dividends
There have been no dividends for Apellis Pharmaceuticals (APLS).